Abstract
Morphological, physiological and pharmacological evidence indicates that opioid peptides, which in the brain are located intraneurally1, may function as neurotransmitters. Similar evidence is not yet available for the opioid peptides that are stored in chromaffin cells of adrenal medulla2–5 and in axon terminals located in adrenal medulla and sympathetic ganglia3–5. The present report contributes evidence suggesting that the opioid peptides which are stored in the axon terminals of the splanchnic nerves located in adrenal medulla4 may function as neuromodulators of the acetylcholine receptors located on chromaffin cells that are involved in catecholamine release. We support this functional role of the opioid peptides by showing that primary cultures of chromaffin cells of bovine medulla contain opiate receptors. When these receptors are occupied by specific agonists, the number of nicotinic receptors and the amount of catecholamine released by maximal doses of nicotine are reduced. Thus, like in other neuronal systems6–8 also in adrenal medulla, the action of opioid peptides is inhibitory. The specificity of this action is in part supported by the inability of opiate receptor agonists to reduce the Ca2+-dependent release of catecholamines elicited by K+ ions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schultzberg, M. et al. Neuroscience 4, 249–270 (1979).
Di Giulio, A. M. et al. Neuropharmacology 17, 989–992 (1978).
Di Giulio, A. M., Yang, H.-Y.T., Fratta, W. & Costa, E. Nature 278, 646–647 (1979).
Schultzberg, M. et al. Neuroscience 3, 1169–1186 (1978).
Costa, E., Di Giulio, A. M., Fratta, W., Hong, J. & Yang, H.-Y.T. in Catecholamines: Basic and Clinical Frontiers (eds Usdin, E., Kopin, I. J. & Barchas, J.) 1020–1025 (Pergamon, New York, 1979).
Nicoll, R. A., Siggins, G. R., Ling, N., Bloom, F. E. & Guillemin, R. Proc. natn. Acad. Sci. U.S.A. 74, 2584–2588 (1977).
Zieglgansberger, W. & Tulloch, I. F. in Endorphins in Mental Health Research (eds Usdin, E., Bunney, W. & Kline, N. S.) 293–301 (Macmillan, London, 1979).
Frederickson, R. C. A. & Norris, F. H. Science 194, 440–442 (1976).
Waymire, J. C., Waymire, K. G., Boehme, R., Noritake, D. & Wardell, J. in Structure and Function of Monoamine Enzymes (eds Usdin, E., Weiner N. & Youdim, M. B. H.) 327–363 (Dekker, New York, 1977).
Kumakura, K., Guidotti, A. & Costa, E. in Catecholamines: Basic and Clinical Frontiers (eds Usdin, E., Kopin, I. J. & Barchas, J.) 61–63 (Pergamon, New York, 1979).
Kumakura, K., Guidotti, A. & Costa, E. Molec. Pharmac. (in the press).
Karoum, F., Garrison, C., Neff, N. H. & Wyatt, R. J. J. Pharmac. exp. Ther. 201, 654–661 (1977).
Karoum, F., Gillin, J. C., Wyatt, R. J. & Costa, E. Biomed. Mass Spectrom. 2, 183–189 (1975).
Neff, N. H., Spano, P. F., Groppetti, A., Wang, C. T. & Costa, E. J. Pharmac. exp. Ther. 176, 701–710 (1971).
Roemer, D. et al. Nature 268, 547–549 (1977).
Pert, C. B. & Bowie, D. L. in Endorphins in Mental Health Research (eds Usdin, E., Bunney, W. E. & Kline, N. S.) 93–104 (Macmillan, London, 1979).
Michelson, M. J. & Danilov, A. F. in Fundamentals of Biochemical Pharmacology (ed. Bacq, Z. M.) 221–253 (Pergamon, New York, 1971).
Wilson, S. P. & Kirshner, N. J. Neurochem. 28, 687–695 (1977).
Morley, B. J., Kemp, G. E. & Salvaterra, P. Life Sci. 24, 859–872 (1979).
Livett, B. C., Kozousek, V., Muzobe, F. & Dean, D. M. Nature 278, 256–257 (1979).
Guillemin, R. et al. Science 197, 1368–1369 (1977).
Costa, E. Adv. biochem. Psychopharmac. (in the press).
Brooks, J. C. Endocrinology 101, 1369–1378 (1977).
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. J. Biochem. 193, 265–275 (1951).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kumakura, K., Karoum, F., Guidotti, A. et al. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells. Nature 283, 489–492 (1980). https://doi.org/10.1038/283489a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/283489a0
This article is cited by
-
Human nicotinic receptors in chromaffin cells: characterization and pharmacology
Pflügers Archiv - European Journal of Physiology (2018)
-
Chromaffin cell biology: inferences from The Cancer Genome Atlas
Cell and Tissue Research (2018)
-
Influence of naloxone on catecholamine release evoked by nicotinic receptor stimulation in the isolated rat adrenal gland
Archives of Pharmacal Research (2005)
-
Ibogaine and the dopaminergic response to nicotine
Psychopharmacology (1997)
-
Catecholamine and MHPG plasma levels, platelet MAO activity, and3H-imipramine binding in heroin and cocaine addicts
Molecular Neurobiology (1995)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.